Tanima De
Regeneron (United States)(US)Geisinger Health System(US)
Publications by Year
Research Areas
Genetic Associations and Epidemiology, Liver Disease Diagnosis and Treatment, Genomics and Rare Diseases, Pharmacogenetics and Drug Metabolism, Blood Coagulation and Thrombosis Mechanisms
Most-Cited Works
- → Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank(2022)172 cited
- → Germline Mutations in CIDEB and Protection against Liver Disease(2022)113 cited
- → The Advantages and Challenges of Diversity in Pharmacogenomics: Can Minority Populations Bring Us Closer to Implementation?(2019)74 cited
- → Screening for inborn errors of metabolism using automated electrospray tandem mass spectrometry: Study in high-risk Indian population(2009)61 cited
- → Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes(2022)52 cited
- → Discovery of novel hepatocyte eQTLs in African Americans(2020)37 cited
- → Gene-level analysis of rare variants in 379,066 whole exome sequences identifies an association of GIGYF1 loss of function with type 2 diabetes(2021)36 cited
- → Cardiovascular Pharmacogenomics: Does It Matter If You're Black or White?(2018)32 cited
- → Association of Genetic Variants With Warfarin-Associated Bleeding Among Patients of African Descent(2018)32 cited
- → Genetic and functional evidence links a missense variant in B4GALT1 to lower LDL and fibrinogen(2021)30 cited